Product
Intravenous hypertonic saline 3%
1 clinical trial
3 indications
Indication
Inhalation TherapyIndication
Hypertonic SalineIndication
Acute Respiratory Distress SyndromeClinical trial
Comparative Study Between the Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress SyndromeStatus: Recruiting, Estimated PCD: 2024-09-01